Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
MARKET--MARCH 2000 Mechanism of Action: Increases tissue insulin sensitivity Clinical Effectiveness: decreased insulin resistance decreased insulinemia reduced fasting and postprandial hyperglycemia in Type II diabetics (non-insulin dependent diabetics, NIDDM) Rosiglitazone* (Avandia)-- FDA approved for management of Type II diabetes Approval as monotherapy or in combination with metformin (Glucophage) might be used with insulin or a sulfonylurea Apparently as effective does troglitazone (Rezulin) in controlling blood glucose without liver toxicity Long-term safety/benefits of rosiglitazone (Avandia) in patients with Type II diabetes: yet to be determined
Deyno S, Eneyew K, Seyfe S, et al
Sinatra answers questions about mitral valve regurgitation, a common heart valve problem
If allergy symptoms occur discontinue use immediately and seek medical attention
US$ 25.00
US$ 26.84
US$ 28.13
US$ 23.23
US$ 23.45
US$ 27.86
